{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:59:23Z","timestamp":1740124763551,"version":"3.37.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013412","name":"Sanofi Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.puhe.2024.02.026","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T09:43:20Z","timestamp":1711791800000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nurses\u2019 preferences regarding MenACWY conjugate vaccines attributes: a discrete choice experiment in Spain"],"prefix":"10.1016","volume":"230","author":[{"given":"J.A.","family":"Forcada-Segarra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Cuesta-Esteve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sancho Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rey Biel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Carrera-Barnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. de la","family":"Cuadra-Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u00c1.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Drago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"G\u00f3mez-Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"L\u00f3pez-Belmonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2024.02.026_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/infdis\/123.1.67","article-title":"Meningococcal carriage in a population of \u2018normal\u2019 families","volume":"123","author":"Greenfield","year":"1971","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.puhe.2024.02.026_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-346-2_1","article-title":"Neisseria meningitidis: biology, microbiology, and epidemiology","volume":"799","author":"Rouphael","year":"2012","journal-title":"Methods Mol Biol Clifton NJ"},{"year":"2018","series-title":"Meningococcal disease. Vaccine knowledge project website [Internet]","key":"10.1016\/j.puhe.2024.02.026_bib3"},{"journal-title":"Solna: ECDC","article-title":"Factsheet about meningococcal disease [Internet]","year":"2019","key":"10.1016\/j.puhe.2024.02.026_bib4"},{"key":"10.1016\/j.puhe.2024.02.026_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.puhe.2024.02.026_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2310\/7060.2005.00006","article-title":"Vaccines in travel health: from risk assessment to priorities","volume":"12","author":"Steffen","year":"2005","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.puhe.2024.02.026_bib7","first-page":"15","article-title":"[Phenotyping of lipoproteinemias in patients with arteriosclerosis by means of paper electrophoresis","volume":"6","author":"Revutski\u012d","year":"1973","journal-title":"Vrach Delo"},{"key":"10.1016\/j.puhe.2024.02.026_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","article-title":"The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations","volume":"18","author":"Acevedo","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.puhe.2024.02.026_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.puhe.2024.02.026_bib10","first-page":"333","article-title":"The situation of vaccines for the prevention of infections in adults: an opinion paper on the situation in Spain","volume":"32","author":"Bouza","year":"2019","journal-title":"Rev Espanola Quimioter Publicacion Soc Espanola Quimioter"},{"journal-title":"Solna: ECDC","article-title":"Meningococcal disease: recommended vaccinations [Internet]","year":"2023","key":"10.1016\/j.puhe.2024.02.026_bib11"},{"year":"2021","series-title":"Agencia Espa\u00f1ola de Protecci\u00f3n de Datos. Ficha T\u00e9cnica de Menquadfi [MenQuadfi Technical File] [Internet]","key":"10.1016\/j.puhe.2024.02.026_bib12"},{"year":"2011","series-title":"Agencia Espa\u00f1ola de Protecci\u00f3n de Datos. Ficha T\u00e9cnica de Menveo [Menveo Technical File] [Internet]","key":"10.1016\/j.puhe.2024.02.026_bib13"},{"year":"2012","series-title":"Agencia Espa\u00f1ola de Protecci\u00f3n de Datos. Ficha T\u00e9cnica de Nimenrix [NimenrixTechnical File] [Internet]","key":"10.1016\/j.puhe.2024.02.026_bib14"},{"year":"2023","series-title":"Calendario com\u00fan de vacunaci\u00f3n a lo largo de toda la vida [Internet]","key":"10.1016\/j.puhe.2024.02.026_bib15"},{"year":"2023","series-title":"Calendarios de vacunaciones espa\u00f1oles [Internet]","author":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (AEP)","key":"10.1016\/j.puhe.2024.02.026_bib16"},{"key":"10.1016\/j.puhe.2024.02.026_bib17","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.anpedi.2021.11.003","article-title":"Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2022","volume":"96","author":"\u00c1lvarez Garc\u00eda","year":"2022","journal-title":"An Pediatr\u00eda"},{"key":"10.1016\/j.puhe.2024.02.026_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bmj.327.7414.542","article-title":"The importance of patient preferences in treatment decisions-challenges for doctors","volume":"327","author":"Say","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2024.02.026_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1748-5908-8-64","article-title":"Integrating evidence on patient preferences in healthcare policy decisions: protocol of the patient-VIP study","volume":"8","author":"Dirksen","year":"2013","journal-title":"Implement Sci IS"},{"year":"2021","author":"de Sanidad","key":"10.1016\/j.puhe.2024.02.026_bib20"},{"key":"10.1016\/j.puhe.2024.02.026_bib21","article-title":"Pliego de prescipciones t\u00e9cnicas para la adquisici\u00f3n de vacuna conjugada frente a meningococo de serogrupos A, C, W, Y destinada al programa de vacunaciones de Castilla-La Mancha en 2022 [Internet]","author":"Consejer\u00eda de Sanidad de Castilla-La Mancha","year":"2021","journal-title":"Toledo: Consejer\u00eda de Sanidad de Castilla-La Mancha"},{"year":"2020","series-title":"Pliego de Cl\u00e1usulas Administrativas para la Adquisici\u00f3n de vacuna conjugada tetravalente frente al meningococo de los serogrupos A, C, W-135 e Y para poblaci\u00f3n de riesgo mayor de 6 semanas de edad [Internet]","author":"Vasco","key":"10.1016\/j.puhe.2024.02.026_bib22"},{"key":"10.1016\/j.puhe.2024.02.026_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health-a checklist: a report of the ISPOR good research practices for conjoint analysis task force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.puhe.2024.02.026_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","article-title":"Multiple criteria decision analysis for health care decision making-an introduction: report 1 of the ISPOR MCDA emerging good practices task force","volume":"19","author":"Thokala","year":"2016","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.puhe.2024.02.026_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","article-title":"Multiple criteria decision analysis for health care decision making-emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force","volume":"19","author":"Marsh","year":"2016","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.puhe.2024.02.026_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.puhe.2024.02.026_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force","volume":"16","author":"Reed Johnson","year":"2013","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"10.1016\/j.puhe.2024.02.026_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/11539650-000000000-00000","article-title":"Conjoint analysis applications in health - how are studies being designed and reported?: an update on current practice in the published literature between 2005 and 2008","volume":"3","author":"Marshall","year":"2010","journal-title":"The Patient"},{"key":"10.1016\/j.puhe.2024.02.026_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/1312067-200801040-00009","article-title":"Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982-2007","volume":"1","author":"Bridges","year":"2008","journal-title":"The Patient"},{"key":"10.1016\/j.puhe.2024.02.026_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00019053-200826080-00004","article-title":"Conducting discrete choice experiments to inform healthcare decision making: a user's guide","volume":"26","author":"Lancsar","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.puhe.2024.02.026_bib31","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2024.02.026_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hec.729","article-title":"Design techniques for stated preference methods in health economics","volume":"12","author":"Carlsson","year":"2003","journal-title":"Health Econ"},{"key":"10.1016\/j.puhe.2024.02.026_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","article-title":"Sample size requirements for discrete-choice experiments in healthcare: a practical guide","volume":"8","author":"de Bekker-Grob","year":"2015","journal-title":"The Patient"},{"key":"10.1016\/j.puhe.2024.02.026_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40271-019-00360-3","article-title":"A\u00a0guide to measuring and interpreting attribute importance","volume":"12","author":"Gonzalez","year":"2019","journal-title":"Patient - Patient-Center Outcomes Res"},{"key":"10.1016\/j.puhe.2024.02.026_bib35","first-page":"1517","article-title":"What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?","author":"Lloyd","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.puhe.2024.02.026_bib36","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/j.vaccine.2015.06.030","article-title":"Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study","volume":"33","author":"De Coster","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2024.02.026_bib37","article-title":"Health care professionals' preference for a fully liquid, ready-to-use hexavalent vaccine in Spain","volume":"22","author":"Cuesta Esteve","year":"2021","journal-title":"Prev Med Rep"},{"year":"2013","series-title":"Orden ESS\/1451\/2013, de 29 de julio, por la que se establecen disposiciones para la prevenci\u00f3n de lesiones causadas por instrumentos cortantes y punzantes en el sector sanitario y hospitalario. [Internet]","key":"10.1016\/j.puhe.2024.02.026_bib38"},{"key":"10.1016\/j.puhe.2024.02.026_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jval.2014.10.010","article-title":"Pediatricians' preferences for infant meningococcal vaccination","volume":"18","author":"Poulos","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.puhe.2024.02.026_bib40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.vaccine.2015.11.075","article-title":"Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a Discrete Choice Experiment","volume":"34","author":"Marshall","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.puhe.2024.02.026_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40121-022-00708-7","article-title":"Societal preferences for meningococcal B vaccination in children: a discrete choice experiment in Spain","volume":"12","author":"Martin\u00f3n-Torres","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.puhe.2024.02.026_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00019053-200725020-00006","article-title":"Conjoint analysis of French and German parents? Willingness to pay for meningococcal vaccine","volume":"25","author":"Bishai","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.puhe.2024.02.026_bib43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40271-017-0244-x","article-title":"Individual preferences for child and adolescent vaccine attributes: a systematic review of the stated preference literature","volume":"10","author":"Michaels-Igbokwe","year":"2017","journal-title":"Patient - Patient-Centered Outcomes Res"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003335062400091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003335062400091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T02:17:21Z","timestamp":1712974641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003335062400091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":43,"alternative-id":["S003335062400091X"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2024.02.026","relation":{},"ISSN":["0033-3506"],"issn-type":[{"type":"print","value":"0033-3506"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nurses\u2019 preferences regarding MenACWY conjugate vaccines attributes: a discrete choice experiment in Spain","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2024.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}]}}